Home/Filings/4/0000899243-23-001626
4//SEC Filing

Katz Barrett 4

Accession 0000899243-23-001626

CIK 0001590750other

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 7:09 PM ET

Size

15.1 KB

Accession

0000899243-23-001626

Insider Transaction Report

Form 4
Period: 2023-01-09
Katz Barrett
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-01-09$23.03/sh+12,623$290,70812,623 total
  • Sale

    Common Stock

    2023-01-09$33.04/sh12,623$417,0640 total
  • Sale

    Common Stock

    2023-01-10$35.30/sh47,377$1,672,4080 total
  • Exercise/Conversion

    Common Stock

    2023-01-10$23.03/sh+47,377$1,091,09247,377 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-01-0912,623343,377 total
    Exercise: $23.03Exp: 2031-01-17Common Stock (12,623 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-01-1047,377296,000 total
    Exercise: $23.03Exp: 2031-01-17Common Stock (47,377 underlying)
Footnotes (3)
  • [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $33.00 to $33.135. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $33.76 to $35.934. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]The option vested 25% on January 18, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.

Issuer

Viridian Therapeutics, Inc.\DE

CIK 0001590750

Entity typeother

Related Parties

1
  • filerCIK 0001841628

Filing Metadata

Form type
4
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 7:09 PM ET
Size
15.1 KB